Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-007155
Filing Date
2025-07-08
Accepted
2025-07-08 12:36:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27692
2 filename2.txt TEXT-EXTRACT 1171
  Complete submission text file 0000000000-25-007155.txt   40183
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filed for) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-288529
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)